molsidomine has been researched along with Cardiovascular Stroke in 53 studies
Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The hemodynamic effects of molsidomine were studied in 48 patients with acute myocardial infarction and compared with hemodynamic properties in a control group of 24 patients." | 9.05 | Hemodynamic effects of molsidomine in patients with acute myocardial infarction. ( Bussmann, WD; Kaltenbach, M; Neidl, K; Reifart, N, 1985) |
| "Haemodynamic monitoring, using a Swan-Ganz balloon catheter, was done in 14 patients with pump failure associated with acute myocardial infarction, before and for 8 h after single 6 mg oral dose of molsidomine." | 7.67 | Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarction. ( Cercós, H; Cohn, JL; Drajer, S; Faerman, G; Nijensohn, CM; Romero, N; Soifer, S; Torres, H; Vazquez, A, 1984) |
| "The short-term hemodynamic effects of molsidomine (4 mg sublingually) were evaluated in 13 patients with congestive heart failure following acute myocardial infarction." | 7.67 | Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction. ( Bracchetti, D; Brunelli, A; Cantelli, I; Lolli, C, 1985) |
| "We studied the effects of molsidomine on hemodynamic properties and blood gas levels in eight patients with acute myocardial infarction and left heart failure." | 7.67 | Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure. ( Bernard, R; Friart, A; Jacobs, P; Liebens, I; Renard, M, 1985) |
| "The unloading mechanisms and side of peripheral action of the new antianginal drug molsidomine was compared with isosorbide dinitrate (ISDN) in 14 patients with acute myocardial infarction using a Swan-Ganz catheter and venous occlusion plethysmography." | 7.66 | Unloading effects of molsidomine on peripheral circulation and cardiac hemodynamics in patients with acute myocardial infarction. ( Hayakawa, H; Kimura, E; Obayashi, K; Rose, HB; Seino, Y; Takano, T; Vyden, JK, 1983) |
| "The hemodynamic effects and duration of action of 4 mg of intravenous molsidomine (M), a new peripheral vasodilator antianginal agent, were evaluated and compared to those of 10 mg sublingual isosorbide dinitrate (ISDN) in 12 patients with uncomplicated acute myocardial infarction (AMI)." | 7.66 | Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction. ( Aptecar, M; Caruso, S; Collia, L; Esteguy, A; Otero y Garzon, CA; Varini, S; Vasquez, A, 1981) |
| "The effect of molsidomine on hemodynamics and myocardial ischemia were studied in 48 patients with acute myocardial infarction." | 7.66 | [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)]. ( Bussmann, WD; Kaltenbach, M; Neidl, K, 1982) |
| " The long-term use of the peripheral vasodilator molsidomin effectively prevents heart failure in myocardial infarction survivors." | 5.27 | [Comparative efficacy of the long-term use of long-acting nitroglycerin (sustak) and molsidomine after myocardial infarct complicated by heart failure]. ( Dormidontov, EN; Petrov, DV, 1986) |
| "In a multicenter, randomized and double-blind study, the efficiency of molsidomine on infarct size has been examined in 303 patients suffering from a first myocardial infarction and compared with a placebo." | 5.06 | The influence of molsidomine on infarct size: an acute post-infarction pilot study with 303 patients. ( Beaufils, P; Castaigne, A; Haiat, R; Kolsky, H; Slama, R, 1988) |
| "The hemodynamic effects of molsidomine were studied in 48 patients with acute myocardial infarction and compared with hemodynamic properties in a control group of 24 patients." | 5.05 | Hemodynamic effects of molsidomine in patients with acute myocardial infarction. ( Bussmann, WD; Kaltenbach, M; Neidl, K; Reifart, N, 1985) |
| "Hemodynamic effects of vasodilator agents (molsidomine, nitroglycerin, isosorbide dinitrate or prostaglandin I2) were studied in 53 patients with acute myocardial infarction." | 3.67 | Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction. ( Kodama, K; Koretsune, Y; Nanto, S; Taniura, K, 1984) |
| "Haemodynamic monitoring, using a Swan-Ganz balloon catheter, was done in 14 patients with pump failure associated with acute myocardial infarction, before and for 8 h after single 6 mg oral dose of molsidomine." | 3.67 | Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarction. ( Cercós, H; Cohn, JL; Drajer, S; Faerman, G; Nijensohn, CM; Romero, N; Soifer, S; Torres, H; Vazquez, A, 1984) |
| "In this report we present the results of hemodynamic monitoring with a Swan-Ganz balloon catheter in 14 patients with heart failure associated with acute myocardial infarction, before and during 8 hours after a single oral dose of molsidomine (6 mg)." | 3.67 | Molsidomine in the treatment of acute heart failure. ( Cercós, H; Cohn, JL; Drajer, S; Faerman, G; Nijensohn, CM; Romero, N; Soifer, S; Torres, H; Vazquez, A, 1985) |
| "The short-term hemodynamic effects of molsidomine (4 mg sublingually) were evaluated in 13 patients with congestive heart failure following acute myocardial infarction." | 3.67 | Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction. ( Bracchetti, D; Brunelli, A; Cantelli, I; Lolli, C, 1985) |
| "We studied the effects of molsidomine on hemodynamic properties and blood gas levels in eight patients with acute myocardial infarction and left heart failure." | 3.67 | Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure. ( Bernard, R; Friart, A; Jacobs, P; Liebens, I; Renard, M, 1985) |
| "The unloading mechanisms and side of peripheral action of the new antianginal drug molsidomine was compared with isosorbide dinitrate (ISDN) in 14 patients with acute myocardial infarction using a Swan-Ganz catheter and venous occlusion plethysmography." | 3.66 | Unloading effects of molsidomine on peripheral circulation and cardiac hemodynamics in patients with acute myocardial infarction. ( Hayakawa, H; Kimura, E; Obayashi, K; Rose, HB; Seino, Y; Takano, T; Vyden, JK, 1983) |
| "The hemodynamic effects and duration of action of 4 mg of intravenous molsidomine (M), a new peripheral vasodilator antianginal agent, were evaluated and compared to those of 10 mg sublingual isosorbide dinitrate (ISDN) in 12 patients with uncomplicated acute myocardial infarction (AMI)." | 3.66 | Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction. ( Aptecar, M; Caruso, S; Collia, L; Esteguy, A; Otero y Garzon, CA; Varini, S; Vasquez, A, 1981) |
| "The effect of molsidomine on hemodynamics and myocardial ischemia were studied in 48 patients with acute myocardial infarction." | 3.66 | [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)]. ( Bussmann, WD; Kaltenbach, M; Neidl, K, 1982) |
| "The occurrence of sudden cardiac death (SCD) in patients with silent ischemia after myocardial infarction (MI) and the factors facilitating SCD are unknown." | 2.74 | Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]). ( Abbate, A; Erne, P; Jamshidi, P; Kobza, R; Pfisterer, M; Schoenenberger, AW; Stuck, AE; Zuber, M, 2009) |
| "Linsidomine is a direct donor of EDRF/NO which has an action on blood vessels (reduction of preload and dilatation of the large epicardial coronary vessels) and on platelets (inhibition of aggregation) without risk of tolerance." | 2.68 | [Linsidomine, direct donor of EDRF/NO: a new treatment for unstable angina]. ( Charansonney, O; Delonca, J; Giraud, T; Lennuyeux, E, 1996) |
| "In 28 patients with unstable angina pectoris biplane coronary angiography was performed in the acute stage." | 2.65 | [Dynamics of critical stenosis in patients with unstable angina pectoris]. ( Karsch, KR; Niemczyk, P; Seipel, L; Voelker, W, 1984) |
| "Allopurinol-treated hearts had significantly decreased nerve growth factor expression, which was substantially increased after coadministration of 3-morpholinosydnonimine." | 1.37 | Differential effects of NADPH oxidase and xanthine oxidase inhibition on sympathetic reinnervation in postinfarct rat hearts. ( Chen, CC; Hsu, YJ; Lee, TM, 2011) |
| "molsidomine was given over 48 h and a number of platelet functions was evaluated before and 3, 24, and 48 h after therapy." | 1.28 | [Effect of molsidomine infusion on thrombocyte function in acute myocardial infarct]. ( Fischer, U; Hiller, E; Riess, H; von Essen, R, 1991) |
| " The long-term use of the peripheral vasodilator molsidomin effectively prevents heart failure in myocardial infarction survivors." | 1.27 | [Comparative efficacy of the long-term use of long-acting nitroglycerin (sustak) and molsidomine after myocardial infarct complicated by heart failure]. ( Dormidontov, EN; Petrov, DV, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (56.60) | 18.7374 |
| 1990's | 17 (32.08) | 18.2507 |
| 2000's | 4 (7.55) | 29.6817 |
| 2010's | 2 (3.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schoenenberger, AW | 2 |
| Kobza, R | 1 |
| Jamshidi, P | 1 |
| Zuber, M | 2 |
| Abbate, A | 1 |
| Stuck, AE | 1 |
| Pfisterer, M | 2 |
| Erne, P | 2 |
| Fan, Q | 1 |
| Yang, XC | 1 |
| Liu, Y | 1 |
| Wang, LF | 1 |
| Liu, SH | 1 |
| Ge, YG | 1 |
| Chen, ML | 1 |
| Wang, W | 1 |
| Zhang, LK | 1 |
| Irwin, MG | 1 |
| Xia, Z | 1 |
| Lee, TM | 1 |
| Chen, CC | 1 |
| Hsu, YJ | 1 |
| Burckhardt, D | 1 |
| Kiowski, W | 1 |
| Dubach, P | 1 |
| Resink, T | 1 |
| Kodama, K | 1 |
| Koretsune, Y | 1 |
| Nanto, S | 1 |
| Taniura, K | 1 |
| Karsch, KR | 1 |
| Niemczyk, P | 1 |
| Voelker, W | 1 |
| Seipel, L | 1 |
| Senenko, AN | 1 |
| Ipatov, PV | 1 |
| Krynskiĭ, OM | 1 |
| Kuznetsov, EI | 1 |
| Drajer, S | 2 |
| Cercós, H | 2 |
| Torres, H | 2 |
| Vazquez, A | 3 |
| Cohn, JL | 2 |
| Romero, N | 2 |
| Faerman, G | 2 |
| Soifer, S | 2 |
| Nijensohn, CM | 2 |
| Nitz, RE | 2 |
| Mogilev, AM | 1 |
| Göbel, H | 2 |
| Seino, Y | 1 |
| Vyden, JK | 1 |
| Rose, HB | 1 |
| Takano, T | 1 |
| Obayashi, K | 1 |
| Hayakawa, H | 1 |
| Kimura, E | 1 |
| Hiroe, M | 1 |
| Sekiguchi, M | 1 |
| Hirosawa, K | 1 |
| Shibata, J | 1 |
| Gasilin, VS | 1 |
| Kramer, AA | 1 |
| Samoilenko, LE | 1 |
| Aptecar, M | 2 |
| Otero y Garzon, CA | 1 |
| Vasquez, A | 1 |
| Varini, S | 1 |
| Collia, L | 1 |
| Esteguy, A | 1 |
| Caruso, S | 1 |
| Fiedler, VB | 2 |
| Belov, Iu | 1 |
| Daskalov, T | 1 |
| Chichovski, K | 1 |
| Kusitasev, G | 1 |
| Popnikolov, S | 1 |
| Bussmann, WD | 2 |
| Neidl, K | 2 |
| Kaltenbach, M | 2 |
| Bassenge, E | 2 |
| Buchheim, S | 1 |
| Charchoglian, RA | 1 |
| Esin, NN | 1 |
| Belozerov, GE | 1 |
| Foucher-Lavergne, A | 1 |
| Kolsky, H | 2 |
| Spreux-Varoquaux, O | 1 |
| Delonca, J | 2 |
| Beaufils, P | 2 |
| Sardina, M | 1 |
| Mizrahi, J | 1 |
| Djonlagic, H | 1 |
| Funke, K | 2 |
| Lessmann, J | 2 |
| Nitsche, K | 1 |
| Kreymann, G | 2 |
| Lipke, M | 1 |
| Fuchs, M | 2 |
| Honikel, HJ | 1 |
| Fehske, W | 1 |
| Zentgraf, B | 1 |
| Costard-Jäckle, A | 1 |
| Nowak, FG | 1 |
| Milstrey, HR | 1 |
| Schmidt, EG | 1 |
| Simon, H | 1 |
| Krüger, R | 1 |
| Grewe, R | 3 |
| Münzel, T | 1 |
| Kasper, W | 1 |
| Just, H | 1 |
| Hiller, E | 2 |
| Fischer, U | 2 |
| von Essen, R | 2 |
| Klüsener, W | 1 |
| Richard, V | 2 |
| Kaeffer, N | 2 |
| Tron, C | 2 |
| Thuillez, C | 2 |
| Blanc, T | 1 |
| Giraud, T | 1 |
| Lennuyeux, E | 1 |
| Charansonney, O | 1 |
| Aitchison, KA | 1 |
| Coker, SJ | 1 |
| Yamamoto, T | 1 |
| Bing, RJ | 1 |
| Maunoury, C | 1 |
| Sébahoun, S | 1 |
| Le Feuvre, C | 1 |
| Antonietti, T | 1 |
| Barritault, L | 1 |
| Sinzinger, H | 1 |
| Riess, H | 1 |
| Siminiak, T | 1 |
| Wysocki, H | 1 |
| Szczepanik, A | 1 |
| Wautier, JL | 1 |
| Renard, M | 2 |
| Verhoeven, A | 1 |
| Liebens, I | 2 |
| Bernard, R | 2 |
| Dormidontov, EN | 1 |
| Petrov, DV | 2 |
| Eremina, EE | 1 |
| Mikhaĭlovich, VA | 1 |
| Ruksin, VV | 1 |
| Haiat, R | 1 |
| Castaigne, A | 1 |
| Slama, R | 1 |
| Khal'fen, ESh | 1 |
| Shvarts, IL | 1 |
| Zolotarev, VA | 1 |
| Cantelli, I | 1 |
| Lolli, C | 1 |
| Brunelli, A | 1 |
| Bracchetti, D | 1 |
| Kipshidze, NN | 1 |
| Chapidze, GE | 1 |
| Marsagishvili, LA | 1 |
| Kapanadze, SD | 1 |
| Avalishvili, LA | 1 |
| Degré, S | 1 |
| Sobolski, J | 1 |
| Berkenboom, G | 1 |
| Abramowicz, M | 1 |
| Vandermoten, P | 1 |
| Stoupel, E | 1 |
| Mindlin de Aptecar, FR | 1 |
| Reifart, N | 1 |
| Jacobs, P | 1 |
| Friart, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Single-blinded Placebo-controlled Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)[NCT02506062] | 21 participants (Actual) | Interventional | 2015-07-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for molsidomine and Cardiovascular Stroke
| Article | Year |
|---|---|
Nitric oxide donors.
Topics: Animals; Aspirin; Drug Tolerance; Heart; Humans; In Vitro Techniques; Molsidomine; Myocardial Infarc | 2000 |
[Role of molsidomine on platelet activation in coronary ischemia].
Topics: Angina Pectoris; Angina, Unstable; Humans; Molsidomine; Myocardial Infarction; Platelet Aggregation | 1988 |
[Pharmacological bases of therapeutic tolerance].
Topics: Animals; Drug Tolerance; Humans; Molsidomine; Muscle, Smooth; Myocardial Contraction; Myocardial Inf | 1988 |
18 trials available for molsidomine and Cardiovascular Stroke
| Article | Year |
|---|---|
Sudden cardiac death in patients with silent myocardial ischemia after myocardial infarction (from the Swiss Interventional Study on Silent Ischemia Type II [SWISSI II]).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Angioplasty, Balloon, Coronary; Antihypertensi | 2009 |
Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans.
Topics: Aged; Angioplasty, Balloon, Coronary; Animals; Apoptosis; Disease Models, Animal; Dose-Response Rela | 2011 |
Effects of anti-ischaemic drug therapy in silent myocardial ischaemia type I: the Swiss Interventional Study on Silent Ischaemia type I (SWISSI I): a randomized, controlled pilot study.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Adult; Aged; Amlodipine; Bisoprolol; Death, Su | 2007 |
[Dynamics of critical stenosis in patients with unstable angina pectoris].
Topics: Angina Pectoris; Angina, Unstable; Coronary Angiography; Coronary Circulation; Coronary Disease; Hem | 1984 |
[Clinical study of the preparation korvatone].
Topics: Clinical Trials as Topic; Female; Heart Aneurysm; Heart Failure; Hemodynamics; Humans; Male; Middle | 1982 |
Hemodynamics, tolerability, and pharmacokinetics of linsidomine (SIN-1) infusion during the acute phase of uncomplicated myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans; Infusions, In | 1993 |
The ESPRIM trial: short-term treatment of acute myocardial infarction with molsidomine. European Study of Prevention of Infarct with Molsidomine (ESPRIM) Group.
Topics: Administration, Oral; Double-Blind Method; Female; Hospital Mortality; Humans; Infusions, Intravenou | 1994 |
[Continuous molsidomine infusion in acute myocardial infarct. Comparison with nitroglycerin infusion].
Topics: Aged; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Molsidomine; Myocardi | 1994 |
[Hemodynamics effects of continuous infusion of molsidomine and nitrates and subsequent oral medication in therapy of acute myocardial infarct].
Topics: Administration, Oral; Aged; Aged, 80 and over; Female; Hemodynamics; Humans; Infusions, Intravenous; | 1994 |
[Intravenous infusion of molsidomine in infarct therapy].
Topics: Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Exercise Te | 1994 |
[Effect of molsidomine infusion on thrombocyte function in acute myocardial infarct].
Topics: Aged; Bleeding Time; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Molsidomine; Myocard | 1994 |
[Bolus molsidomine administration for induction of parenteral molsidomine therapy in acute myocardial infarct. Effect on systemic blood pressure].
Topics: Adult; Aged; Blood Pressure; Coronary Circulation; Dose-Response Relationship, Drug; Drug Administra | 1994 |
[Linsidomine, direct donor of EDRF/NO: a new treatment for unstable angina].
Topics: Adult; Aged; Angina, Unstable; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug | 1996 |
[Synergism of PGI2 and molsidomine in arterial occlusive disease].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Coronary Thrombosis; Drug Synergism; Drug Therapy, Co | 1991 |
The influence of isosorbide dinitrate and molsidomine on migration of polymorphonuclear neutrophils in vivo.
Topics: Acute Disease; Cell Movement; Humans; Isosorbide Dinitrate; Molsidomine; Muscle, Smooth, Vascular; M | 1990 |
The influence of molsidomine on infarct size: an acute post-infarction pilot study with 303 patients.
Topics: Acute Disease; Aged; Double-Blind Method; Female; Humans; Middle Aged; Molsidomine; Myocardial Infar | 1988 |
Molsidomine--an effective antianginal drug. Results of an acute randomized stress-testing study.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Humans; | 1985 |
Hemodynamic effects of molsidomine in patients with acute myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Clinical Trials as Topic; Hemodynamics; Humans; Molsidomine; Myocard | 1985 |
32 other studies available for molsidomine and Cardiovascular Stroke
| Article | Year |
|---|---|
Differential effects of NADPH oxidase and xanthine oxidase inhibition on sympathetic reinnervation in postinfarct rat hearts.
Topics: Acetophenones; Allopurinol; Animals; Arrhythmias, Cardiac; Coronary Vessels; Ethidium; Male; Molsido | 2011 |
Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
Topics: Blood Pressure; Cardiac Output; Coronary Circulation; Epoprostenol; Female; Heart Failure; Heart Rat | 1984 |
[Changes in blood pressure in the pulmonary artery in myocardial infarct].
Topics: Adult; Aged; Blood Pressure; Female; Heart Rate; Humans; Hypertension, Pulmonary; Male; Middle Aged; | 1984 |
Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarction.
Topics: Aged; Antihypertensive Agents; Cardiac Catheterization; Cardiac Output; Female; Heart Failure; Hemod | 1984 |
Anti-ischemic effects of molsidomine in an experimental model of coronary artery stenosis.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Coronary Disease; Dogs; Electrocardiography; Femal | 1983 |
Unloading effects of molsidomine on peripheral circulation and cardiac hemodynamics in patients with acute myocardial infarction.
Topics: Adult; Aged; Blood Circulation; Blood Flow Velocity; Central Venous Pressure; Female; Heart Failure; | 1983 |
Hemodynamic assessment in the medical treatment of acute myocardial infarction: the effects of various vasodilators and catecholamines.
Topics: Adult; Aged; Blood Circulation; Catecholamines; Dopamine; Female; Heart Rupture; Hemodynamics; Human | 1981 |
The effect of some antianginal drugs on the myocardial perfusion in patients with ischaemic heart disease.
Topics: Adult; Angina Pectoris; Coronary Circulation; Coronary Disease; Coronary Vessels; Delayed-Action Pre | 1981 |
Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemodynamics; Humans | 1981 |
Effects of molsidomine on coronary artery thrombosis and myocardial ischemia in acute canine experiments.
Topics: Animals; Blood Coagulation; Coronary Disease; Disease Models, Animal; Dogs; Female; Hemodynamics; Ma | 1981 |
[Effect of korvatone on hemodynamics in the acute stage of myocardial infarct].
Topics: Antihypertensive Agents; Drug Evaluation; Heart Function Tests; Hemodynamics; Humans; Molsidomine; M | 1981 |
[Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].
Topics: Administration, Oral; Blood Pressure; Cardiac Output; Coronary Disease; Heart Rate; Hemodynamics; Hu | 1982 |
[Pharmacological basis of therapy with molsidomine].
Topics: Angina Pectoris; Animals; Biological Availability; Coronary Vessels; Hemodynamics; Humans; Molsidomi | 1982 |
Effects of molsidomine and dopamine infusion on the size of canine experimental myocardial infarct.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Dopamine; Female; Heart Rate; Male; Molsidomine; Myoc | 1982 |
Molsidomine.
Topics: Humans; Molsidomine; Myocardial Infarction; Survival Rate | 1994 |
[The hemodynamic effectiveness of molsidomine infusions in patients with acute coronary insufficiency].
Topics: Aged; Angina, Unstable; Cardiac Output; Dose-Response Relationship, Drug; Drug Administration Schedu | 1994 |
[Continuous molsidomine infusions in patients with unstable angina pectoris and acute myocardial infarct].
Topics: Adult; Aged; Angina, Unstable; Dose-Response Relationship, Drug; Drug Administration Schedule; Femal | 1994 |
Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion.
Topics: Acetylcholine; Animals; Arginine; Calcimycin; Coronary Vessels; Endothelium, Vascular; Male; Molsido | 1994 |
Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide.
Topics: Acetylcholine; Animals; Arginine; Blood Pressure; Coronary Vessels; Disease Models, Animal; Endothel | 1995 |
Potential interactions between iloprost and SIN-1 on platelet aggregation and myocardial infarct size in vivo.
Topics: Animals; Arrhythmias, Cardiac; Creatine Kinase; Drug Synergism; Electrocardiography; Hemodynamics; I | 1999 |
Value of linsidomin in assessing myocardial viability with thallium-201 SPECT.
Topics: Aged; Cell Survival; Female; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; | 2001 |
[Effect of molsidomine infusion on thrombocyte function in acute myocardial infarct].
Topics: Aged; beta-Thromboglobulin; Bleeding Time; Female; Humans; Infusions, Intravenous; Male; Middle Aged | 1991 |
Blood gas and hemodynamic changes induced by the treatment of pulmonary congestion with vasodilators in the acute phase of myocardial infarction.
Topics: Adult; Aged; Carbon Dioxide; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; I | 1986 |
[Comparative efficacy of the long-term use of long-acting nitroglycerin (sustak) and molsidomine after myocardial infarct complicated by heart failure].
Topics: Adult; Aged; Delayed-Action Preparations; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Mi | 1986 |
[Effect of peripheral vasodilators on hemodynamics in the acute period of a myocardial infarct].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Female; Hemodynamics; Humans; Male; Middle Aged; Mols | 1987 |
[Effect of corvaton on ischemic left-ventricular damage and hemodynamic indicators in patients with acute myocardial infarction].
Topics: Adult; Aged; Coronary Circulation; Female; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged | 1988 |
[Long-term use of the peripheral vasodilator corvaton in the polyclinic stage of rehabilitation of patients with myocardial infarction and subclinical manifestations of circulatory insufficiency (clinico-hemodynamic study)].
Topics: Adult; Aged; Angina Pectoris; Hemodynamics; Humans; Middle Aged; Molsidomine; Myocardial Contraction | 1987 |
Molsidomine in the treatment of acute heart failure.
Topics: Aged; Cardiac Catheterization; Female; Hemodynamics; Humans; Male; Middle Aged; Molsidomine; Myocard | 1985 |
Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
Topics: Aged; Female; Heart Failure; Hemodynamics; Humans; Male; Molsidomine; Myocardial Infarction; Oxadiaz | 1985 |
[Intravenous administration of molsidomin in the acute period of myocardial infarct].
Topics: Humans; Injections, Intravenous; Molsidomine; Myocardial Infarction; Oxadiazoles; Sydnones | 1985 |
Comparison of the influence of nitrates, molsidomine and SIN-1, a molsidomine metabolite in acute coronary insufficiency.
Topics: Coronary Circulation; Coronary Vasospasm; Coronary Vessels; Ergonovine; Humans; Molsidomine; Myocard | 1985 |
Effects of molsidomine on hemodynamics and blood gases in acute myocardial infarction with left heart failure.
Topics: Aged; Carbon Dioxide; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Mols | 1985 |